Publication:

Mechanism of TRIM25 Catalytic Activation in the Antiviral RIG-I Pathway

Loading...
Thumbnail Image

Open/View Files

Date

2016

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Sanchez, Jacint G., Jessica J. Chiang, Konstantin M.J. Sparrer, Steven L. Alam, Michael Chi, Marcin D. Roganowicz, Banumathi Sankaran, Michaela U. Gack, and Owen Pornillos. 2016. “Mechanism of TRIM25 Catalytic Activation in the Antiviral RIG-I Pathway.” Cell reports 16 (5): 1315-1325. doi:10.1016/j.celrep.2016.06.070. http://dx.doi.org/10.1016/j.celrep.2016.06.070.

Abstract

SUMMARY Antiviral response pathways induce interferon by higher-order assembly of signaling complexes called signalosomes. Assembly of the RIG-I signalosome is regulated by K63-linked polyubiquitin chains, which are synthesized by the E3 ubiquitin ligase, TRIM25. We have previously shown that the TRIM25 coiled-coil domain is a stable, antiparallel dimer that positions two catalytic RING domains on opposite ends of an elongated rod. We now show that the RING domain is a separate self-association motif that engages ubiquitin-conjugated E2 enzymes as a dimer. RING dimerization is required for catalysis, TRIM25-mediated RIG-I ubiquitination, interferon induction, and antiviral activity. We also provide evidence that RING dimerization and E3 ligase activity are promoted by binding of the TRIM25 SPRY domain to the RIG-I effector domain. These results indicate that TRIM25 actively participates in higher-order assembly of the RIG-I signalosome and helps to fine-tune the efficiency of the RIG-I-mediated antiviral response.

Description

Research Data

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories